These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 8504277)
1. Transfer by BMT of IgG2 deficiency involving an immunoglobulin heavy chain constant region deletion and a silent IgG2 gene. Olsson PG; Gustafson R; Hammarström V; Lönnqvist B; Smith CI; Hammarström L Bone Marrow Transplant; 1993 May; 11(5):409-14. PubMed ID: 8504277 [TBL] [Abstract][Full Text] [Related]
2. Two siblings with deficiency of IgA1, IgG2, IgG4 and IgE due to deletion of immunoglobulin heavy chain constant region genes. Plebani A; Carbonara AO; Bottaro A; Gallina R; Boccazzi C; Crispino P; Ruggeri L; Soresina A; Meini A; Duina M Year Immunol; 1993; 7():231-5. PubMed ID: 8372508 [No Abstract] [Full Text] [Related]
3. Immunologic compensation in a patient with a large IgH constant region deletion. Depiero A; Kaminski DA; Halsey JF; Briles D; Burrows PD; Hostoffer RW J Allergy Clin Immunol; 2001 Jun; 107(6):1051-5. PubMed ID: 11398084 [TBL] [Abstract][Full Text] [Related]
4. Gene deletion as a cause of associated deficiency of IgA1, IgG2, IgG4 and IgE. Plebani A; Carbonara AO; Bottaro A; Gallina R; Boccazzi C; Crispino P; Ruggeri L; Salvioni F; Duina M; Negrini A Immunodeficiency; 1993; 4(1-4):245-8. PubMed ID: 8167710 [No Abstract] [Full Text] [Related]
5. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946 [TBL] [Abstract][Full Text] [Related]
6. A recurrent breakpoint in the most common deletion of the Ig heavy chain locus (del A1-GP-G2-G4-E). Brusco A; Saviozzi S; Cinque F; Bottaro A; DeMarchi M J Immunol; 1999 Oct; 163(8):4392-8. PubMed ID: 10510380 [TBL] [Abstract][Full Text] [Related]
7. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. Juckett M; Rowlings P; Hessner M; Keever-Taylor C; Burns W; Camitta B; Casper J; Drobyski WR; Hanson G; Horowitz M; Lawton C; Margolis J; Peitryga D; Vesole D Bone Marrow Transplant; 1998 May; 21(9):893-9. PubMed ID: 9613781 [TBL] [Abstract][Full Text] [Related]
8. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695 [TBL] [Abstract][Full Text] [Related]
9. The genetics of IgG4 deficiency: role of the immunoglobulin heavy chain constant region and HLA loci. Gallina R; Bottaro A; Boccazzi C; DeLange G; Danese P; Mazzola G; Amoroso A; DeMarchi M; Carbonara AO Eur J Immunol; 1992 Jan; 22(1):227-33. PubMed ID: 1346112 [TBL] [Abstract][Full Text] [Related]
10. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124 [TBL] [Abstract][Full Text] [Related]
11. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia. Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205 [TBL] [Abstract][Full Text] [Related]
12. Selective IgG2 deficiency due to a point mutation causing abnormal splicing of the Cgamma2 gene. Zhao Y; Pan-Hammarström Q; Zhao Z; Wen S; Hammarström L Int Immunol; 2005 Jan; 17(1):95-101. PubMed ID: 15569770 [TBL] [Abstract][Full Text] [Related]
13. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048 [TBL] [Abstract][Full Text] [Related]
14. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets. Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075 [TBL] [Abstract][Full Text] [Related]
15. Molecular basis of selective IgG2 deficiency. The mutated membrane-bound form of gamma2 heavy chain caused complete IGG2 deficiency in two Japanese siblings. Tashita H; Fukao T; Kaneko H; Teramoto T; Inoue R; Kasahara K; Kondo N J Clin Invest; 1998 Feb; 101(3):677-81. PubMed ID: 9449702 [TBL] [Abstract][Full Text] [Related]
17. Gene deletions in the human immunoglobulin heavy chain constant region locus: molecular and immunological analysis. Lefranc MP; Hammarström L; Smith CI; Lefranc G Immunodefic Rev; 1991; 2(4):265-81. PubMed ID: 1905558 [TBL] [Abstract][Full Text] [Related]
18. [Basedow disease occurring after allogeneic bone marrow transplantation for acute lymphoblastic leukemia]. Sasaki Y; Ito K Rinsho Ketsueki; 2002 Sep; 43(9):833-5. PubMed ID: 12412287 [TBL] [Abstract][Full Text] [Related]
19. Molecular and serologic analysis of IgG1 deficiency caused by new forms of the constant region of the Ig H chain gene deletions. Smith CI; Hammarström L; Henter JI; de Lange GG J Immunol; 1989 Jun; 142(12):4514-9. PubMed ID: 2498432 [TBL] [Abstract][Full Text] [Related]
20. Human IGHC locus restriction fragment length polymorphisms in IgG4 deficiency: evidence for a structural IGHC defect. Bottaro A; DeMarchi M; DeLange GG; Boccazzi C; Fubini L; Borra C; Cappello N; Carbonara AO Eur J Immunol; 1989 Nov; 19(11):2159-62. PubMed ID: 2574682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]